Fractional exhaled nitric oxygen in asthma patients
Mengarelli C, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A, López A, Rey-Ares L
Record ID 32016001114
Spanish
Authors' recommendations:
Evidence of low methodological quality suggests that fractional exhaled nitric oxide to monitor glucocorticoid therapy in adult asthma patients might reduce the number of exacerbations, while the evidence in pediatric patients is not enough. When comparing the clinical assessment (with or without spirometry) in treatment monitoring, the exhaled fraction might have moderate sensitivity and specificity.
Most of the clinical practice guidelines identified do not recommend its use.
Some United States private sponsors cover the test while others consider it at experimental stage.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Humans
- Asthma
- Breath Tests
- Fractional Exhaled Nitric Oxide Testing
- Nitric Oxide
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
<p>Institute for Clinical Effectiveness and Health Policy (IECS)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.